Maven Securities LTD Evaxion Biotech A/S Transaction History

Maven Securities LTD

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$4.0 - $12.68 $891,224 - $2.83 Million
-222,806 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$5.32 - $9.65 $68,096 - $123,520
-12,800 Reduced 5.43%
222,806 $2.15 Million
Q2 2021

Aug 16, 2021
BUY
$5.2 - $7.94 $26,000 - $39,700
5,000 Added 2.17%
235,606 $1.76 Million
Q1 2021

May 17, 2021
BUY
$5.3 - $9.95 $1.22 Million - $2.29 Million
230,606 New
230,606 $1.27 Million

Others Institutions Holding EVAX

# of Institutions
1
Shares Held
37.5K
Call Options Held
0
Put Options Held
0
View Full List

About Evaxion Biotech A/S

EVAX Quotes by TradingView
  • Ticker EVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,977,900
  • Market Cap $33.8M
  • Description
  • Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Ph...
More about EVAX
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email